Journal
BLOOD
Volume 106, Issue 12, Pages 3880-3887Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2005-03-1201
Keywords
-
Categories
Ask authors/readers for more resources
The human plasma protein beta(2)-glycoprotein I (beta(2)-GPI) is the most common target for antiphospholipid antibodies associated with thrombotic events in chronic disorders related to endothelial cell dysfunction. Crucial information is needed to clarify why this self-abundant protein is targeted by autoimmune responses. In this study, we investigated whether oxidative modification of beta(2)-GPI, either spontaneous in culture wells or induced by treatment with H2O2, renders this self-protein able to activate immature monocyte-derived dendritic cells (DCs) from healthy human donors. Oxidized beta(2)-GPI caused DCs to mature so that CD83 appeared and CD80, CD86, human leukocyte antigen-D region related (HLA-DR), and CD40 increased. The interaction between oxidized beta(2)-GPI and DCs specifically stimulated these cells to secrete interleukin 12 (IL-12), IL-1 beta, IL-6, IL-8, tumor necrosis factor alpha (TNF-alpha), and IL-10. Oxidized beta(2)-GPI-stimulated DCs had increased allostimulatory ability and primed naive T lymphocytes, thus inducing T helper 1 (Th1) polarization. The interaction between oxidized beta(2)-GPI and DCs involved interleukin-1 receptor associated kinase (IRAK) phosphorylation and nuclear factor kappa B (NF kappa B) activation. Pretreatment Of beta(2)-GPI with the antioxidant alpha-tocopherol prevented DC maturation. These findings show that human oxidized beta(2)-GPI, probably by interacting with a member of the Toll-like receptor (TLR) family, causes DCs to mature. Because this key beta(2)-GPI function requires oxidative modification, in several chronic disorders related to endothelial cell dysfunction oxidative stress might trigger the autoimmune spiral.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available